Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. | Director | Common Stock | 10.9K | $171K | $15.78 | Dec 26, 2023 | Direct |
Edgewise Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.6K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EWTX | Edgewise Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
EWTX | Edgewise Therapeutics, Inc. | Dec 26, 2023 | 1 | $101K | 4 | Dec 28, 2023 | Director |
EWTX | Edgewise Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
EWTX | Edgewise Therapeutics, Inc. | Mar 3, 2023 | 1 | $0 | 4 | Mar 7, 2023 | Director |
EWTX | Edgewise Therapeutics, Inc. | Mar 2, 2023 | 0 | $0 | 3 | Mar 7, 2023 | Director |